Unique pathological findings of astroblastoma with MN1 alteration in a patient with late recurrence

1.

Ahmed KA, Allen PK, Mahajan A, Brown PD, Ghia AJ (2014) Astroblastomas: A Surveillance, Epidemiology, and End Results (SEER)-Based Patterns of Care Analysis. World Neurosurg 82:e291–e297

Article  Google Scholar 

2.

Bell JW, Osborn AG, Salzman KL, Blaser SI, Jones BV, Chin SS (2007) Neuroradiologic characteristics of astroblastoma. Neuroradiology 49:203–209

Article  Google Scholar 

3.

Brat DJ, Hirose Y, Cohen KJ, Feuerstein BG, Burger PC (2000) Astroblastoma: Clinicopathologic features and chromosomal abnormalities defined by comparative genomic hybridization. Brain Pathol 10:342–352

CAS  Article  Google Scholar 

4.

Chen W, Soon YY, Pratiseyo PD, Sutanto R, Hendriansyah L, Kuick CH, Chang KTE, Tan CL (2020) Central nervous system neuroepithelial tumors with MN1-alteration: an individual patient data meta-analysis of 73 cases. Brain Tumor Pathol 37:145–153

CAS  Article  Google Scholar 

5.

Hirose T, Nobusawa S, Sugiyama K, Amatya VJ, Fujimoto N, Sasaki A, Mikami Y, Kakita A, Tanaka S, Yokoo H (2018) Astroblastoma: a distinct tumor entity characterized by alterations of the X chromosome and MN1 rearrangement. Brain Pathol 28:684–694

CAS  Article  Google Scholar 

6.

Ho CY, Vandenbussche CJ, Huppman AR, Chaudhry R, Ali SZ (2015) Cytomorphologic and clinicoradiologic analysis of primary nonhematologic central nervous system tumors with positive cerebrospinal fluid. Cancer Cytopathol 123:123–135

Article  Google Scholar 

7.

Janz C, Buhl R (2014) Astroblastoma: report of two cases with unexpected clinical behavior and review of the literature. Clin Neurol Neurosurg 125:114–124

Article  Google Scholar 

8.

Lehman NL, Usubalieva A, Lin T, Allen SJ, Tran QT, Mobley BC, McLendon RE, Schniederjan MJ, Georgescu MM, Couce M, Dulai MS, Raisanen JM, Abbadi MA, Palmer CA, Hattab EM, Orr BA (2019) Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis. Acta Neuropathol Commun 7:42

Article  Google Scholar 

9.

Louis DN, Ohgaki H, Wiestler OD, Cavanee WK, Ellison DW, Figarella-Branger D, et al (2016) World Health Organization Classification of Tumors of the Central Nervous System. revised 4t. Lyon, France

10.

Mhatre R, Sugur HS, Nandeesh BN, Chickabasaviah Y, Saini J, Santosh V (2019) MN1 rearrangement in astroblastoma: study of eight cases and review of literature. Brain Tumor Pathol 36:112–120

CAS  Article  Google Scholar 

11.

Sturm D, Orr BA, Toprak UH et al (2016) New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164:1060–1072

CAS  Article  Google Scholar 

12.

Sughrue ME, Choi J, Rutkowski MJ, Aranda D, Kane AJ, Barani IJ, Parsa AT (2011) Clinical features and post-surgical outcome of patients with astroblastoma. J Clin Neurosci 18:750–754

Article  Google Scholar 

13.

Wood MD, Tihan T, Perry A, Chacko G, Turner C, Pu C, Payne C, Yu A, Bannykh SI, Solomon DA (2018) Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities. Brain Pathol 28:192–202

CAS  Article  Google Scholar 

留言 (0)

沒有登入
gif